Molecular Variability in Levodopa Absorption and Clinical Implications for the Management of Parkinson's Disease

Abstract

Levodopa is the most widely used medication for the symptomatic treatment of Parkinson's disease and, despite being an 'old' drug, is still considered the gold standard for offering symptomatic relief. The pharmacokinetic and pharmacodynamics of levodopa have been studied extensively. Our review explores the molecular mechanisms that affect the absorption of this drug, focusing on the large intra- and interindividual variability of absorption that is commonly encountered in daily clinical practice, and on the interaction with other medications. In addition, we will explore the clinical implications of levodopa absorption variability and address current and future strategies for researchers and clinicians.